Abstract:Histone deacetylases (HDACs) are a superfamily of enzymes that catalyze the removal of acetyl functional groups from lysine residues of histone and non-histone proteins. There are 18 mammalian HDACs, which are classified into four classes based on the primary homology with yeast HDACs. Among these groups, Class I and II HDACs play a major role in lysine deacetylation of the N-terminal histone tails. In mammals, HDACs play a pivotal role in the regulation of gene transcription, cell growth, survival, and proliferation. HDACs regulate the expression of inflammatory genes, as evidenced by the potent anti-inflammatory activity of pan-HDAC inhibitors, which were implicated in several pathophysiologic states in the inflammation process. However, it is unclear how each of the 18 HDAC proteins specifically contributes to the inflammatory gene expression. It is firmly established that inflammation and its inability to converge are central mechanisms in the pathogenesis of several cardiovascular diseases (CVDs). Emerging evidence supports the hypothesis that several different pro-inflammatory cytokines regulated by HDACs are associated with various CVDs. Based on this hypothesis, the potential for the treatment of CVDs with HDAC inhibitors has recently begun to attract attention. In this review, we will briefly discuss (1) pathophysiology of inflammation in cardiovascular disease, (2) the function of HDACs in the regulation of atherosclerosis and cardiovascular diseases, and (3) the possible therapeutic implications of HDAC inhibitors in cardiovascular diseases. Recent studies reveal that histone deacetylase contributes critically to mediating the pathophysiology of inflammation in cardiovascular disease. HDACs are also recognized as one of the major mechanisms in the regulation of inflammation and cardiovascular function. HDACs show promise in developing potential therapeutic implications of HDAC inhibitors in cardiovascular and inflammatory diseases.

The role of class IIa histone deacetylases in regulating endothelial function

Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis

Classical HDACs in the Regulation of Neuroinflammation.

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

The Role of Histone Protein Acetylation in Regulating Endothelial Function

Targeting Histone Deacetylases: Perspectives for Epigenetic-Based Therapy in Cardio-Cerebrovascular Disease

Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases

Histone Deacetylases (hdacs) and Atherosclerosis: A Mechanistic and Pharmacological Review

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis

Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases

Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases.

Class Ⅱ members of histone deacetylases and clinic significance

Targeting histone deacetylase in cardiac diseases

Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow

Role of histone deacetylases and their inhibitors in neurological diseases

Histone Deacetylases and Their Inhibitors: Molecular Mechanisms and Therapeutic Implications in Diabetes Mellitus

Targeting histone deacetylases for heart diseases

Research Advances of Histone Deacetylase and Cardiovascular Diseases

Histone Deacetylase 5 Interacts with Krüppel-like Factor 2 and Inhibits Its Transcriptional Activity in Endothelium.

HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs